布里斯托尔·迈耶斯第四季度的收益超过预期, 但股票评级保持稳定. Bristol Myers Q4 earnings beat estimates, but stock rating is hold.

布里斯托尔·迈耶斯·斯奎伯的第四季度收益低于预期,收入略高于预计. Bristol Myers Squibb reported Q4 earnings below estimates, with revenue slightly beating expectations. 公司维持了2026年每股6.05至6.35美元的利预期. The company maintained its 2026 earnings guidance of $6.05 to $6.35 per share. 该股票收到了分析师评级的混合,一些公司赋予"超重量"观点,导致共识 "持有" 评价和平均目标价格为61.35美元. The stock received a mix of analyst ratings, with some firms assigning "overweight" views, resulting in a consensus "hold" rating and an average price target of $61.35.